Publication date: November 2026 Source: JTO Clinical and Research Reports, Volume 7, Issue 11 Author(s): Ryan T. Hughes, Paul J. Black, India R. Wood, Anna C. Snavely, Beverly J. Levine, Justin M. Napolitano, Heather D. Pacholke, Janardhana Ponnatapura, Kathryn E. Weaver, Glenn J. Lesser, Sun H. Park, Jeffrey S. Willey, Michael K. Farris
Effect of Risedronate on Rib Cortical Thickness After Stereotactic Body Radiotherapy to Peripheral Lung Tumors: Results of a Randomized Phase 2 Trial. // JTO Clinical and Research Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2666364326001207?dgcid=rss_sd_all
Effect of Risedronate on Rib Cortical Thickness After Stereotactic Body Radiotherapy to Peripheral Lung Tumors: Results of a Randomized Phase 2 Trial. JTO Clinical and Research Reports. https://www.sciencedirect.com/science/article/pii/S2666364326001207?dgcid=rss_sd_all
“Effect of Risedronate on Rib Cortical Thickness After Stereotactic Body Radiotherapy to Peripheral Lung Tumors: Results of a Randomized Phase 2 Trial.” JTO Clinical and Research Reports.
@article{article56911,
title = {Effect of Risedronate on Rib Cortical Thickness After Stereotactic Body Radiotherapy to Peripheral Lung Tumors: Results of a Randomized Phase 2 Trial},
journal = {JTO Clinical and Research Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2666364326001207?dgcid=rss_sd_all}
}